Literature DB >> 2367313

Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.

L A al-Razzak1, A E Benedetti, W N Waugh, V J Stella.   

Abstract

Pentostatin, an unusual nucleoside of natural origin, has been used for the treatment of hairy cell leukemia, as an immunosuppressant agent, and as an inhibitor of adenosine deaminase. The studies of the physicochemical properties and solution stability of pentostatin are important to the development of a parenteral formulation for extensive preclinical and clinical testing. Pentostatin displayed apparent pKa values at 25 +/- 0.1 degree C and ionic strength of 0.15 M of 2.03 +/- 0.03 and 5.57 +/- 0.14 (spectrophotometric) and 5.50 +/- 0.02 (potentiometric) for N1 and the amidine nitrogen in the seven-membered ring, respectively, which are the most likely protonation sites. The rates of degradation of pentostatin were determined as a function of pH, buffer concentration, and temperature. In the pH range 1.0-4.0, pentostatin undergoes acid-catalyzed glycosidic cleavage leading to the formation of the base compound, and 2-deoxyribose. A carbonium ion mechanism in which C-N bond cleavage was the rate-determining step was consistent with the data. In the pH range 6.5-10.5, the imine bond at C5 position in pentostatin is hydrolyzed to form the corresponding formamide. Pentostatin hydrolysis in this pH range was independent of pH. At pH greater than 11, pentostatin decomposes to nonchromophoric products probably through multiple-step base-catalyzed hydrolytic mechanisms. Pentostatin appears to be quite stable after reconstitution of a lyophilized experimental dosage form. Care must be taken if pentostatin is extensively diluted with 5% dextrose in water, as pentostatin stability is compromised at pH values less than 5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367313     DOI: 10.1023/a:1015852329748

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Kinetics and mechanism of the hydrolysis of guanosine and 7-methylguanosine nucleosides in perchloric acid.

Authors:  J A Zoltewicz; D F Clark
Journal:  J Org Chem       Date:  1972-04-21       Impact factor: 4.354

2.  Solvolysis of adenine nucleosides. I. Effects of sugars and adenine substituents on acid solvolyses.

Authors:  E R Garrett; P J Mehta
Journal:  J Am Chem Soc       Date:  1972-11-29       Impact factor: 15.419

3.  Solvolysis of adenine nucleosides. II. Effects of sugars and adenine substituents on alkaline solvolyses.

Authors:  E R Garrett; P J Mehta
Journal:  J Am Chem Soc       Date:  1972-11-29       Impact factor: 15.419

4.  Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides.

Authors:  J A Zoltewicz; D F Clark; T W Sharpless; G Grahe
Journal:  J Am Chem Soc       Date:  1970-03-25       Impact factor: 15.419

5.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

Review 6.  Antiviral agents as adjuncts in cancer chemotherapy.

Authors:  W M Shannon; F M Schabel
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

7.  Low-dose deoxycoformycin in the treatment of hairy cell leukemia.

Authors:  E H Kraut; B A Bouroncle; M R Grever
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.